Industry partnering opportunity with VIC Technology Venture Development
Watch the webinar
Enter your details below to access the audio and video recording of this event, and to receive updates about future virtual events.
If you’re already subscribed to IN-PART, please enter your details and you’ll be taken to the recordings.
In the second event of our latest Virtual Series, we spoke with Danielle France, Fellow and Michael Artinger, VP and Managing Director, at VIC Technology Venture Development – who source top medtech and biotech innovation from research institutions around the world and form new companies to commercialise the chosen technologies. We heard about their R&D priorities and the research they’re looking for from academia.
What’s covered in this event?
- 00:00 – Introduction to the event from IN-PART
- 03:23 – Introduction to VIC
- 13:57 – How VIC is different
- 22:59 – R&D priorities and academic partnering opportunities
- 26:19 – Live Q&A
- 34:45 – Closing remarks
Format: Presentation followed by live Q&A (~40 minutes)
As part of our current Global Challenge campaign on the human microbiome, VIC Technology Ventures have shared their interests through this webinar and in a one-page summary (company interests and priorities), with the view to identify new academic partners for collaboration and commercialisation partnerships.
About VIC Technology Ventures: VIC select technologies that provide the most significant commercial opportunities and highest societal impacts. VIC forms new companies to commercialise the chosen technologies. While VIC’s primary focus is on forming life science companies, they also have founded companies in high-impact areas such as clean water, animal health, food safety, and automotive crash safety.
There are over 10 times as many microbial cells in the human body as there are human cells. These cells make up the human microbiome, communities of microbes, including bacteria and fungi that have greater complexity than the human genome itself. The microbiome can found in multiple sites across the human body for example, the gut, skin, and oral and nasal cavities which all have a different community of microbes.
As the key interface between the body and the environment, the human microbiome has extensive functions to protect us against pathogens, develop immunity and aid in digestion and metabolism.
In the first events of our Virtual Series, running alongside our latest Global Challenges campaign, we’ll be speaking with external innovation and R&D leads at a number of companies in the microbiome space to hear about the roadblocks they face, and the priority research they’re looking for from academia to support their product and R&D pipelines.
Some of the topics covered will include:
- The top priorities and technical challenges for each company
- What research solutions companies are actively searching for from academia
- The companies’ preferred approaches to partnering with academic research and expertise
Who should attend?
- Technology transfer, research commercialisation + industry engagement teams
- Academic researchers
- Industry R&D and open/external innovation teams
Run in partnership with:
ASTP are Europe’s premier association of knowledge transfer professionals whose work aims to improve the quality of impact that public research has on the economy and society. Learn more.
PraxisAuril are a world-leading professional association for knowledge exchange practitioners, whose network includes 5000+ KE professionals. Learn more.
What is IN-PART?
IN-PART develops digital solutions, curated by in-house STEM experts, that simplify the initial connection between decision-makers in academia and industry. Our goal is to help drive impact from research by matching innovation and expertise on a level playing field globally.
Connect, a digital partnering platform for university-industry collaboration.
An online matchmaking platform used by 250+ universities and research institutes to connect with industry teams in 6,000+ companies to commercialise academic innovations and expertise that are available and seeking collaboration.
Discover, a bespoke scouting service for open innovation.
A bespoke scouting platform used by innovation-driven companies to profile the global landscape of academia across an active network of 2,400+ institutes, either through ‘Industry Calls for Opportunities’ or ‘Request for Proposal’ campaigns that find and confirm potential solutions to specific R&D challenges or requirements.